Full-Time

Senior Manager of Clinical Product

InStride Health

InStride Health

201-500 employees

Virtual pediatric mental health care coordination

Compensation Overview

$130k - $145k/yr

Remote in USA

Remote

Fully virtual, with periodic in-person retreats.

Bachelor's, Master's, PhD, Certification

Category
Product (1)

Get referred to InStride Health

See people who can refer or advise you

Requirements
  • PhD or PsyD in psychology from an accredited school of psychology, LICSW from an accredited school of social work, or LMHC and a master's degree from an accredited graduate program.
  • Advanced clinical background and education focused on children, adolescents, and young adults with anxiety, obsessive-compulsive disorder, related disorders, and common comorbidities.
  • Experience and training in evidence-based treatments such as cognitive behavioral therapy, exposure and response prevention, acceptance and commitment therapy, and dialectical behavior therapy, with appropriate provider licensure.
  • Experience creating engaging, evidence-based clinical materials for children, teens, and young adults, and tailoring them by age.
  • Ability to translate complex clinical and operational concepts into clear content and protocols.
  • Demonstrated curiosity about artificial intelligence and a trajectory of adopting new tools.
  • Enthusiasm for applying artificial intelligence responsibly to improve care and comfort partnering with technical teams to shape and adopt artificial-intelligence-enabled clinical tools.
  • Demonstrated ability to work cross-functionally with multiple stakeholders in a high-growth, entrepreneurial environment.
  • Strategic prioritization, independent judgment, and flexibility amid change.
  • Strong clinical judgment and comfort making decisions where structure is still being built, with willingness for the role to evolve as the clinical product matures.
  • Excellent written and interpersonal communication skills, and cultural competence regarding diversity and inclusion.
Responsibilities
  • Serve as an internal expert on the InStride care model and evidence-based practices for anxiety, obsessive-compulsive disorder, related disorders, and frequently co-occurring conditions.
  • Act as a trusted clinical resource and innovator for specialty content, supporting internal teams and external stakeholder collaboration.
  • Stay current with emerging best practices and integrate new approaches into the clinical product.
  • Produce, review, and coordinate evidence-based clinical content for external audiences, including blogs, webinars, thought leadership, website content, and educational resources, in partnership with the Growth team.
  • Partner with the Growth team to accurately represent InStride’s clinical offerings in external materials, including patient populations, clinical indications, and each offering’s place in the broader care model.
  • Represent InStride’s clinical work in public-relations opportunities and external partner meetings.
  • Prepare clinical content, protocols, and training for expansion into new age bands, payers, and conditions.
  • Tailor evidence-based content across the developmental span from young children to young adults and adapt it for new populations.
  • Provide clinical expertise for evaluating and developing new populations and conditions aligned with InStride’s care model and evidence base.
  • Build and continuously improve training, protocols, and clinical resources for complex, high-acuity, avoidance-driven presentations of anxiety, obsessive-compulsive disorder, and related disorders.
  • Design and deliver ongoing care-team training for therapists, exposure coaches, and psychiatrists.
  • Strengthen care-team confidence and consistency in high-acuity cases, reducing avoidable escalations, dropouts, and referrals out.
  • Serve as a clinical resource for supervisors and care-team leaders on complex cases and specialized expertise, and translate emerging research into practical guidance for frontline providers.
  • Help lead the responsible integration of artificial intelligence into clinical care, partnering with Tech Product to shape tools and feedback loops.
  • Translate clinical requirements into responsible artificial-intelligence products and build training and change management for care-team adoption.
  • Identify where artificial intelligence can improve care effectiveness, consistency, and scalability.
  • Design artificial-intelligence-enabled workflows that support clinician utilization and help protect against burnout.
  • Lead regular updates to the curriculum, Provider Guide, and clinical protocols, and develop new clinical materials as needed.
  • Evaluate content and protocols to identify and close gaps, and support a standardized feedback loop with Clinical Operations.
  • Partner with Design to align materials with the InStride brand and provide an engaging, user-friendly experience.
  • Provide timely clinical consultation, feedback, and guidance across teams and contribute to additional clinical protocols, tools, and content as priorities evolve.
  • Support regular care-team communication touchpoints.
  • Contribute to strategic enablers and major clinical initiatives.
  • Serve as the therapy subject matter expert on cross-functional teams, providing clinical input to Tech Product and Design.
  • Facilitate one to two parent, caregiver, and/or patient groups and provide clinical evaluation coverage as needed.
Desired Qualifications
  • Experience working on a clinical product team and interfacing with technology or product partners to build clinical tools.
  • Comfort operating at the intersection of clinical practice and product development.
  • Experience supporting trauma-related presentations and translating that expertise into clinical guidance, training, or resources.

InStride Health delivers evidence-based mental health care for children, teens, and young adults in seven Northeastern states, with a focus on anxiety disorders and OCD. Treatments are delivered virtually through a coordinated care model that pairs therapy, medication management, exposure coaching, and peer support, guided by a three-person team of clinicians, exposure coaches, and peers, with treatment intensity adjusted to each patient. This approach differs from many providers by integrating multiple disciplines into one program and relying on remote delivery with insurance coverage to reduce access barriers, drawing on leadership from Harvard-trained professionals with McLean Hospital experience. The goal is to make pediatric and young-adult mental health care accessible, evidence-based, and effective through insured, coordinated virtual care for anxiety and OCD.

Company Size

201-500

Company Stage

Series C

Total Funding

$86M

Headquarters

Boston, Massachusetts

Founded

2021

Get referred to InStride Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 15, 2026 Series C raised $30 million from Echo Health Ventures and FMZ.
  • InStride served 5,000-plus patients and doubled 2025 enrollment while maintaining outcomes.
  • Most major commercial plans cover InStride; patients often meet clinicians within three days.

What critics are saying

  • Brightline and Little Otter target the same pediatric virtual-mental-health buyers and employers.
  • Rapid expansion into five May 2026 markets strains clinician hiring, payer contracting, and quality.
  • Aetna, Anthem, or UnitedHealthcare contract losses would crush referrals and stall national expansion.

What makes InStride Health unique

  • InStride's 2026 outcomes report showed 97% clinical improvement across 3,604 episodes.
  • Its therapist-coach-psychiatrist model delivers insurance-covered specialty OCD care in 17 states.
  • New markets opened May 2026: Washington, D.C., North Carolina, Florida, Georgia, South Carolina.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Sabbatical Leave

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

1%

2 year growth

1%
MedCity News
Jun 16th, 2026
InStride raises $30M to scale pediatric mental health support.

InStride raises $30M to scale pediatric mental health support. InStride's Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. InStride Health, a pediatric mental health provider, announced Monday that it raised $30 million in Series C funding to expand into new markets. Boston-based InStride Health provides virtual specialty outpatient care for pediatric anxiety and obsessive-compulsive disorder. Its care is grounded in cognitive behavioral therapy, focusing on exposure therapy, in which patients are gradually exposed to situations they fear. The company works with patients aged seven to 24 and their families, providing them with a care team consisting of a therapist, exposure coach and psychiatrist. The team develops a personalized care plan, and patients can communicate with their care team via text, phone or video. The Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. presented by Healthcare payments are no longer about transactions. It's about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. "As behavioral health pivots from access to outcomes, we believe high-quality specialty models like InStride are incredibly well-positioned. They've built the wraparound care and incentive alignment that consistently delivers durable ROI to payors, and have proven their ability to replicate the model across numerous markets at scale. We are excited to support the company in its next phase of growth," said Kurt Sheline, partner at Echo Health Ventures, in a statement. With the funding, InStride Health will expand into new markets while also deepening coverage in existing markets, according to John Voith, co-founder and CEO of InStride. It currently operates in 17 states and has served more than 5,000 patients. "It will help us add specialty capacity for payors and employers in areas where evidence-based care for complex anxiety, OCD, and related disorders is difficult to access, while helping ensure that geography and insurance status are no longer barriers to care," Voith said. "Most importantly, it will enable more young people to access high-quality specialty treatment, graduate from care, and thrive." Recent outcomes data from InStride Health found that 97% of graduates experienced overall clinical improvements and more than 99% of patients remained out of the hospital one year after discharge. In addition, 81% of caregivers reported a reduction in their own stress, and more than 90% reported a reduction in missed work. presented by Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today! Ultimately, the company aims to expand access to evidence-based specialty care for young people, while also maintaining clinical quality, Voith said. "As we grow into new and existing markets, we're focused on ensuring more families can access the high-quality care they need while preserving the strong clinical outcomes that have defined InStride's approach," he said. Other pediatric mental health companies include Brightline and Little Otter.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

HIStalk Practice
Jun 15th, 2026
News 6/15/26.

News 6/15/26. June 15, 2026 News No Comments Top News. InStride Health announces $30 million in Series C funding. The pediatric mental healthcare company offers virtual care for anxiety, OCD, and related disorders in 16 states and Washington, DC. Sponsored events and resources. None scheduled soon. Contact Lorre to have your resource listed. Acquisitions, funding, business, and stock. FYihealth Group secures an undisclosed amount of funding from investment firm KKR. The group, through its subsidiaries, manages 370 optometry clinics and retail locations in Canada and the US. The funding will help the group expand its investment in AI and digital infrastructure. People. Vision Innovation Partners names Brad Foster, MD (Ascend Vision Partners) chief medical and strategy officer. Other. CVS Health Chief Experience and Technology Officer Tilak Mandadi shares details around the personal AI assistant it's working on with Google Cloud as part of the Health100 platform, which will launch later this year: The assistant will aggregate and continuously monitor a member's insurance, pharmacy, and clinical data to proactively offer guidance in real time. Mandadi envisions it pulling data from EHRs, wearables, pharmacy records, and claims data. The Louisiana Department of Health begins offering 250,000 free Phenomune test kits to residents across the state. The kits, which use taste testing strips and an accompanying app to help users understand how their bodies might respond to upper respiratory illnesses. The department hopes the data will enable users to have more informed conversations with their providers and potentially prevent trips to the ER.

Associated Press
May 7th, 2026
InStride Health reports 97% clinical improvement rate as pediatric mental health provider expands to five East Coast states

InStride Health, a provider of paediatric mental healthcare for anxiety and OCD, has released its 2026 Annual Clinical Outcomes Report showing sustained clinical results as it expands services. The retrospective analysis examined 3,604 episodes of care between January 2023 and December 2025. Key findings showed 97% of patients demonstrated clinical improvement, whilst 91% reported reduced anxiety symptoms with an average 53% reduction in anxiety scores. Depression symptoms improved in 93% of patients, with a 54% average reduction in depression scores. Fewer than 1% of patients required hospitalisation in the 12 months following discharge. The company nearly doubled patient enrolment in 2025 whilst maintaining consistent clinical outcomes. InStride is expanding to five new East Coast markets—Washington DC, North Carolina, Florida, Georgia and South Carolina—by early May 2026.

406 Ventures
May 7th, 2026
InStride Health wins Mental Health Innovation Award in 2026 MedTech Breakthrough Awards program.

InStride Health wins Mental Health Innovation Award in 2026 MedTech Breakthrough Awards program. BOSTON, May 7, 2026 - InStride Health, the leading provider of specialty mental health care for youth with complex anxiety, OCD, and related disorders, has been named the winner of the Mental Health Innovation Award in the 2026 MedTech Breakthrough Awards program. Conducted by MedTech Breakthrough, an independent market intelligence organization focused on digital health and medical technology, the program recognizes top companies, technologies and products worldwide. InStride Health was recognized for its virtual care model designed to treat moderate to severe pediatric anxiety and OCD. At the core of InStride's model is a dedicated care team for each patient, including a psychiatrist, therapist and exposure coach, who guide treatment based on cognitive behavioral therapy (CBT), the gold standard treatment for anxiety and OCD. Their virtual approach enables care teams to support young people beyond traditional weekly sessions, providing coaching during real-world exposures while coordinating with caregivers, schools and other members of a child's support system. Supporting this care model is InStride's purpose-built AI tools, trained on domain-specific data to drive increasingly personalized care for families. Over the past year, the company has enhanced AI capabilities to better support clinical decision-making and care coordination, helping ensure consistent, high-quality care delivery. "Too many young people with anxiety and OCD are falling through the cracks of a system that was never designed for the complexity of their needs," said Kathryn Boger, Ph.D., ABPP, co-founder and Chief Clinical Officer of InStride Health. "We're reimagining how specialty mental health care gets delivered, combining world-class clinical expertise with AI-powered tools that make coordinated, real-world care possible at scale. This recognition reflects the outcomes we're delivering: helping young people build the skills to get back to living their lives." The mission of the MedTech Breakthrough Awards is to honor excellence and recognize innovation across a range of health and medical technology categories including telehealth, patient engagement, and digital health platforms. This year's program attracted thousands of nominations from organizations around the world, underscoring the significance of InStride Health's recognition in advancing pediatric mental health care. About InStride Health: InStride Health is the leading provider of specialty mental health care for youth with complex anxiety, OCD, and related disorders - one of the fastest-growing and most underserved areas in healthcare. Spun out of the nation's top-ranked psychiatric hospital, InStride translates decades of clinical research into a scalable, real-world care model that delivers evidence-based Cognitive Behavioral Therapy (CBT) and exposure therapy virtually, supported by a dedicated team of psychiatrists, therapists, and exposure coaches. This care model is enhanced by AI tools trained on a proprietary, domain-specific dataset that compounds with every patient, driving increasingly personalized care and improving outcomes over time. The company partners closely with parents, schools, and external providers, coordinating across settings to provide surround sound skills that enable graduation from specialty care. InStride is in-network with most major commercial insurance plans, and patients typically connect with a clinician within days and begin treatment within weeks. Now operating across 17 states with a repeatable, payer-backed model, InStride is scaling nationwide to help young people reclaim their lives from anxiety and OCD. Learn more at www.instride.health. Media contact: